Lheureux S, Cristea MC, Bruce JP, Garg S, et al. Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 2021;397:281-292.
PMID: 33485453